Diffusion Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$15,210,676 over the previous period. Total operating expenses were $15,972,180.

Profit Margin

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN): Profit margin
2013 71.66K -2.46M -3438.61%
2014 0 -14.35M
2015 0 -23.82M
2016 0 -18.03M
2017 0 -1.36M
2018 0 -18.36M
2019 0 -11.79M
2020 0 -14.18M
2021 0 -24.09M
2022 0 -15.21M

DFFN Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
00000000071.66K
Cost of revenue
0000000000
Gross profit
00000000071.66K
Operating exp.
Research and development
7.23M8.49M9.42M6.61M5.75M5.08M7.25M3.85M2.86M0
Selling and marketing
0000000000
Total operating expenses
15.97M16.03M15.97M11.55M12.02M11.34M18.37M12.75M7.94M6.82M
Operating income
-15.97M-24.67M-15.97M-11.55M-18.95M11.34M18.37M-23.82M-14.61M-12.91M
Other income (expenses), net
380.75K137.48K114.25K85.30K-6.92M-13.76M-36.77M6.35K-2.55M4.52M
Income before tax
-15.59M-24.53M-15.86M-11.46M-18.80M-2.42M-18.40M-23.82M-17.16M-2.45M
Income tax expense
-380.75K-443.89K-1.67M332.88K-437.28K-1.05M-364.79K11.07M-2.81M499.91K
Net income
-15.21M-24.09M-14.18M-11.79M-18.36M-1.36M-18.03M-23.82M-14.35M-2.46M
Earnings per share
Basic EPS
-7.46-18.57-19.76-131.95-283.28-82.44-1.32K-6.81K-7.53K-3.17K
Diluted EPS
-11.19-18.57-19.76-131.95-283.28-80.45-1.32K-6.81K-7.53K-3.17K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source